Pharmacokinetics and in vivo specificity of [LLC]dl-threo-methylphenidate for the presynaptic dopaminergic neuron
- 12 October 1994
- Vol. 18 (2), 152-160
- https://doi.org/10.1002/syn.890180207
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Monoamine neurons in aging and Alzheimer's diseaseJournal of Neural Transmission, 1993
- SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primatesSynapse, 1993
- Regional distribution and kinetics of haloperidol binding in human brain: A pet study with [18F]haloperidolSynapse, 1992
- In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine‐123 labeled RTI‐55Synapse, 1992
- Possible mechanisms underlying the special vulnerability of dopaminergic neuronsActa Neurologica Scandinavica, 1991
- Evidence that Dogs Do Not Model Enantioselective Pharmacokinetics of dl-Methylphenidate in HumansJournal of Pharmaceutical Sciences, 1991
- A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1990
- Synthesis of racemic (+) and (−) N-[methyl-11C]nomifensine, a ligand for evaluation of monoamine re-uptake sites by use of positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1989
- [3H]GBR-12935 Binding to the Dopamine Transporter Is Decreased in the Caudate Nucleus in Parkinson's DiseaseJournal of Neurochemistry, 1987
- A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDRENJournal of Child Psychology and Psychiatry, 1977